Authors


Susan Tan-Torres, MD, MPH

Latest:

Collaborative DTM Reduces Hospitalization and Healthcare Costs in Patients With Diabetes Treated With Polypharmacy

Drug therapy management implementation in 2 health plans resulted in significant cost savings and modest to significant reductions in emergency department visits and inpatient admissions among patients with diabetes.


Emily C. Pherson, PharmD, BCPS

Latest:

Pharmacy Team Engagement in Navigating the Revenue Cycle for High-Cost Medications in Patients With Cancer

With the clinical and financial implications of high-cost medications, and their impact on health system revenue, it is of utmost importance for all key stakeholders to be engaged in the complex revenue cycle.


Kuang-Hua Huang, PhD

Latest:

Effects of Multidisciplinary Team Care on Utilization of Emergency Care for Patients With Lung Cancer

Impact of multidisciplinary team care on reducing utilization of emergency department visits for patients with lung cancer.


Asaf Bitton, MD

Latest:

Alignment of Breast Cancer Screening Guidelines, Accountability Metrics, and Practice Patterns

This study measured breast cancer screening practice patterns in relation to evidence-based guidelines and accountability metrics, and found closer alignment is needed for providing patient-centered care.


Chester W. Schmidt, Jr, MD

Latest:

Telemedicine and the Sharing Economy: The "Uber" for Healthcare

Telehealth platforms will promote increased competition in the marketplace for medical care delivery, benefiting both consumers and clinicians.



David M. Mosen, PhD, MPH

Latest:

More Comprehensive Discussion of CRC Screening Associated With Higher Screening

More comprehensive discussion of colorectal screening by primary care physicians was associated with higher screening rates among adults aged 51 to 80 years who were overdue for screening.


Jeffrey S. McCombs, PhD

Latest:

Primary Nonadherence to Medications in an Integrated Healthcare Setting

This retrospective study measures primary nonadherence rates for 10 drug groups and identifies important factors of primary nonadherence for chronic and acute medications.


Ping Zhang, PhD

Latest:

Medical Costs Associated With Type 2 Diabetes Complications and Comorbidities

A large proportion of medical costs for type 2 diabetes are attributable to complications and comorbidities, especially end stage renal disease with dialysis or kidney transplantation.


Bita Kash, PhD, MBA, FACHE

Latest:

The Pediatric Medical Home: What Do Evidence-Based Models Look Like?

This study presents practice relevant information and actionable results that can help to operationalize evidence-based patient-centered medical home models in pediatric clinics.




Steven D. Culler, PhD

Latest:

Impact of Electronic Information Exchange on Repeat Imaging During 30-Day Readmissions Among Medicare Beneficiaries

This analysis of Medicare data examines the relationships between fragmented readmission, health information exchange, and repeat imaging in older adults with and without Alzheimer disease.


Steven M. Ornstein, MD

Latest:

"Meaningful" Clinical Quality Measures for Primary Care Physicians

Recommendations from primary care Meaningful Use "exemplars" are that clinical quality measures likely to improve outcomes should be evidence-based, high priority, actionable, and minimize burden.




Tezeta F. Mitiku, BSc, MSc

Latest:

Evaluation of Electronic Medical Record Administrative Data Linked Database (EMRALD)

The combination of electronic medical record data and administrative data provides the fullest picture of patient health histories.


Rajeev K. Sabharwal, MPH

Latest:

Developing Evidence That Is Fit for Purpose: A Framework for Payer and Research Dialogue

A decision-making framework that can be used to harmonize the evidence payer's desire for coverage and formulary decisions with the evidence generated by researchers.


Sean Nicholson, PhD

Latest:

Addressing Health Care Disparities Using a Health Plan Quality Measures Index

The Health Insurance Disparities Index allows stakeholders to assess progress in addressing health care disparities using publicly available, validated, reported health plan quality metrics results.



Thomas Manley, MD

Latest:

Cost-effectiveness of Brentuximab Vedotin With Chemotherapy in Treatment of CD30-Expressing PTCL

An economic model based on the ECHELON-2 trial demonstrated cost-effectiveness of brentuximab vedotin with chemotherapy in frontline treatment of CD30-expressing peripheral T-cell lymphoma (PTCL).



Robin R. Gillies, PhD

Latest:

Relationship Between Quality Improvement Processes and Clinical Performance

This study examines the clinical effects of care management and quality improvement interventions implemented by physician groups on pay-for-performance success.


Maryam Alvandi, RCT, MHS

Latest:

Optimizing the Effect of Electronic Health Records for Healthcare Professionals and Consumers

Electronic databases promote a safe environment for healthcare professionals by facilitating retrospective analysis of errors; however, providers should make significant changes to how they handle patient information.


Asaf Cohen, MD

Latest:

Technology-Driven Intervention to Improve Hypertension Outcomes in Community Health Centers

Health information technology that is implemented as part of a multifaceted quality improvement initiative can lead to improvements in hypertension care and outcomes.


Mangala Rajan, MBA

Latest:

Diabetes, Gaps in Care Coordination, and Preventable Adverse Events

The authors examined the association of diabetes with self-reported gaps in care coordination and self-reported preventable adverse events using data from a national sample of older adults.


Midge N. Ray, MSN, RN

Latest:

Cost Implications of Human and Automated Follow-up in Ambulatory Care

This study examined the costs of nurse-initiated or automated follow-up processes for patients seen in ambulatory care settings


Daniel Polsky, PhD

Latest:

Traditional Medicare Supplemental Insurance and the Rise of Medicare Advantage

Rising Medicare Advantage enrollment occurred alongside declines in enrollment in traditional Medicare with employer-sponsored supplemental coverage and traditional Medicare without supplemental coverage.


Ellen T. Matloff, MS

Latest:

The Angelina Effect: Rising Interest in Genetic Testing Creates Opportunities for Patients-and Profit

Ellen T. Matloff, MS, is a research scientist in the Department of Genetics and the director of cancer genetic counseling at Yale Cancer Center/Yale School of Medicine in New Haven, Connecticut.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo